In addition to tumor type, histological grade, tumor size, and lymph node metastasis status, the patients clinical and demographic characteristics, such as age, gender, lateralization, and immunohistochemical findings, including ER, PR, HER2, and Ki67 results, were assessed, and the associations between these parameters were examined
The results of these studies have been inconsistent and there appears to be a close interplay between GH treatment/exercise and sex steroid therapy on the improvement of muscle mass/strength in sarcopenia with most studies showing that one intervention alone is less likely to lead to increase in muscle mass/strength (Taaffe et al., 1994
Young: Yeah
For GHK-Cu, animal wound and hair-follicle findings should be read as preclinical evidence unless matched by human clinical data [6], [16]